5 research outputs found
Osobitosti anestezije kod ortopedskih zahvata u bolesnika s osteogenesis imperfecta [Characteristics of anesthesia in patients with osteogenesis imperfecta undergoing orthopedic surgical procedures]
The aim is to show our experience in anesthesia of patients with osteogenesis imperfecta (OI) who have undergone orthopedic surgical procedures. This is a retrospective analysis of OI patients treated at our Department from 1980 to 2012. We analyzed demographics, comorbidities, preoperative characteristics, anesthesia types, anesthetics and intraoperative and postoperative complications. In the given period, 26 OI patients were treated, using 103 surgeries, and 103 anesthesia procedures. Most procedures, a total of 68, were used in children aged 0-10 years. According to the diagnosis, OI type III was mostly encountered. The rating of the American Society of Anesthesiologist (ASA) physical status was II in most cases, a total of 99. General anesthesia was used in 89 cases, and regional anesthesia in 14. Fourteen intraoperative complications were seen, mostly difficult intubation, and six postoperative cardiovascular instability cases. With careful preparation, and knowledge of pitfalls, anesthesia in these patients should be a safe procedure
CHARACTERISTICS OF ANESTHESIA IN PATIENTS WITH OSTEOGENESIS IMPERFECTA UNDERGOING ORTHOPEDIC SURGICAL PROCEDURES
Prikazujemo svoje iskustvo u anesteziranju bolesnika s osteogenesis imperfectom u sklopu ortopedskoga kirurÅ”kog lijeÄenja prijeloma i deformacija kostiju. UÄinjena je retrospektivna analiza dokumentacije bolesnika lijeÄenih u naÅ”oj Klinici od 1980. do 2012. godine. Analizirani su demografski podaci, komorbiditeti, prijeoperacijske osobitosti, vrste anestezije, anestetika i lijekova te intraoperacijske i poslijeoperacijske komplikacije. U navedenom razdoblju lijeÄeno je 26 bolesnika s navedenom dijagnozom. Zabilježene su 103 operacije, odnosno 103 anestezioloÅ”ka postupka. NajviÅ”e zahvata, njih 68, uÄinjeno je u dobnoj skupini od 0 do 10 godina. NajviÅ”e bolesnika bolovalo je od tipa III osteogenesis imperfecte, najtežeg oblika ove bolesti spojivog sa životom. U 99 operacija zabilježen je ASA (American society of anesthesiologists) status II bolesnika. U 89 sluÄajeva uÄinjena je opÄa anestezija, u 14 regionalna. Zabilježeno je 14 intraoperacijskih komplikacija, najviÅ”e otežanih intubacija te 6 sluÄajeva poslijeoperacijske kardiovaskularne nestabilnosti. Uz kvalitetnu pripremu i predviÄanje moguÄih komplikacija anestezija u ovih bolesnika sigurna je procedura.The aim is to show our experience in anesthesia of patients with osteogenesis imperfecta (OI) who have undergone orthopedic surgical procedures. This is a retrospective analysis of OI patients treated at our Department from 1980 to 2012. We analyzed demographics, comorbidities, preoperative characteristics, anesthesia types, anesthetics and intraoperative and postoperative complications. In the given period, 26 OI patients were treated, using 103 surgeries, and 103 anesthesia procedures. Most procedures, a total of 68, were used in children aged 0ā10 years. According to the diagnosis, OI type III was mostly encountered. The rating of the American Society of Anesthesiologist (ASA) physical status was II in most cases, a total of 99. General anesthesia was used in 89 cases, and regional anesthesia in 14. Fourteen intraoperative complications were seen, mostly difficult intubation, and six postoperative cardiovascular instability cases. With careful preparation, and knowledge of pitfalls, anesthesia in these patients should be a safe procedure
Utjecaj tromboprofilakse fondaparinuksom u usporedbi s nadroparin kalcijem na kliniÄke parametre nakon ugradnje potpune endoproteze koljena
Fondaparinux has been shown to be as effective as low molecular weight heparin in orthopedic surgery, with no cases of heparin induced thrombocytopenia proven until today. The main goal of this prospective randomized controlled trial was to define whether thromboprophylaxis in patients with primary osteoarthritis of the knee undergoing total knee arthroplasty (TKA) influences clinical parameters in the same manner in patients receiving fondaparinux as in those receiving nadroparin during the first 7 postoperative days. Sixty patients with primary knee osteoarthritis underwent unilateral TKA performed by the same surgeon and were randomized into two groups of 30 patients receiving either fondaparinux or nadroparin thromboprophylaxis. Patients were compared according to the duration of operation, perioperative blood loss, laboratory results and clinical evaluation of the edema during the early postoperative period. No diff erences were found between the groups in the mean duration of surgery, perioperative blood loss, and most of laboratory results. The level of urea was significantly lower in the nadroparin group on the first and second postoperative day. No cases of heparin induced thrombocytopenia, deep vein thrombosis or pulmonary embolism were noted during the study. Study results showed both fondaparinux and nadroparin to have the same influence on clinical parameters during the first 7 postoperative days in patients undergoing TKA.Fondaparinuks se pokazao jednako uÄinkovitim u ortopedskim operacijama kao i heparin niske molekularne težine, bez sluÄajeva heparinom izazvane trombocitopenije do danas. Glavni cilj ovoga prospektivnog randomiziranog istraživanja bio je pokazati utjeÄe li tromboprofilaksa fondaparinuksom na bolesnike s primarnom gonartrozom koji su podvrgnuti operacijskom zahvatu ugradnje totalne endoproteze koljena na jednaki naÄin kao i nadroparin tijekom prvih 7 dana nakon operacije. Ukupno 60 bolesnika kod kojih je jednostranu ugradnju totalne endoproteze koljena izveo jedan te isti operater randomizirani su u dvije skupine po 30 bolesnika te je jedna skupina dobivala tromboprofilaksu fondaparinuksom, a druga nadroparinom. Bolesnici su usporeÄivani prema trajanju operacije, perioperacijskom gubitku krvi, laboratorijskim nalazima te kliniÄkoj
evaluaciji edema tijekom ranog poslijeoperacijskog razdoblja. Nisu naÄene razlike u trajanju operacijskog zahvata, perioperacijskom
gubitku krvi niti prema veÄini laboratorijskih nalaza. Razina ureje je bila znaÄajno niža u skupini s nadroparinom tijekom prva dva poslijeoperacijska dana. Nije zabilježen niti jedan sluÄaj heparinom izazvane trombocitopenije, duboke venske tromboze ili pluÄne embolije tijekom ovog istraživanja. NaÅ”i rezultati pokazali su da fondaparinuks i nadroparin na isti naÄin utjeÄu na kliniÄke parametre tijekom prvih 7 poslijeoperacijskih dana od ugradnje totalne endoproteze koljena
Influence of fondaparinux versus nadroparin calcium thromboprophylaxis on clinical parameters following total knee arthroplasty
Fondaparinux has been shown to be as effective as low molecular weight heparin in orthopedic surgery, with no cases of heparin induced thrombocytopenia proven until today. The main goal of this prospective randomized controlled trial was to define whether thromboprophylaxis in patients with primary osteoarthritis of the knee undergoing total knee arthroplasty (TKA) influences clinical parameters in the same manner in patients receiving fondaparinux as in those receiving nadroparin during the first 7 postoperative days. Sixty patients with primary knee osteoarthritis underwent unilateral TKA performed by the same surgeon and were randomized into two groups of 30 patients receiving either fondaparinux or nadroparin thromboprophylaxis. Patients were compared according to the duration of operation, perioperative blood loss, laboratory results and clinical evaluation of the edema during the early postoperative period. No diff erences were found between the groups in the mean duration of surgery, perioperative blood loss, and most of laboratory results. The level of urea was significantly lower in the nadroparin group on the first and second postoperative day. No cases of heparin induced thrombocytopenia, deep vein thrombosis or pulmonary embolism were noted during the study. Study results showed both fondaparinux and nadroparin to have the same influence on clinical parameters during the first 7 postoperative days in patients undergoing TKA
Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty
PURPOSE:
Our aim was to evaluate the effectiveness of two different dosing regimens of human recombinant erythropoietin (rHu-EPO) for preoperative autologous blood collection in patients undergoing total hip arthroplasty (THA). ----- METHODS:
Prospective randomised trials in which erythropoietin 15,000 IU was administered intravenously twice a week or 30,000 IU once a week (total 90,000 IU) combined with ferrous II sulphate (Ferro-Gradumet 2) orally and compared with Ferro-Gradumet 2 alone. ----- RESULTS:
Although different dosing regimens of rHu-EPO administration during preoperative autologous blood donation have similar effects on the collection of two units of autologous blood, preoperative haemoglobin level and perioperative allogenic blood transfusion, a once weekly dose regimen of rHu-EPO was more convenient (although not statistically significantly) for patients. ----- CONCLUSION:
We recommend the more practical and comfortable but yet highly effective therapeutic regimen with a single weekly intravenous administration of rHu-EPO for patients scheduled for THA